CJ, VaxInnate to join forces in flu vaccine production

CJ CheilJedang Corp. announced Monday that it has signed an exclusive licensing agreement with the U.S. based VaxInnate Corporation, a privately-held biotechnology company, granting a license to CJ to manufacture, develop and commercialize VaxInnate’s recombinant seasonal and pandemic flu vaccines in Korea. The agreement also includes a non-exclusive license to market the vaccines in certain So...